PT UBC Medical Indonesia Tbk(ID:LABS)
Rp123.00+1.00 (+0.82%)
ID:LABS
PT UBC Medical Indonesia Tbk financials statements
Rp123.00
At close:+1.00 (+0.82%)
PT UBC Medical Indonesia Tbk (LABS) Income Statement
PT UBC Medical Indonesia Tbk Income Statement
Last quarter (Q3 2026), PT UBC Medical Indonesia Tbk's total revenue was Rp55.32B, an increase of 13.51% from the same quarter last year. In Q3, PT UBC Medical Indonesia Tbk's net income was Rp2.95B. See PT UBC Medical Indonesia Tbk’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Mar 25 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Rp 199.30B | Rp 147.64B | Rp 136.70B | Rp 93.29B | Rp 129.96B | |
| Rp 67.46B | Rp 45.61B | Rp 46.51B | Rp 30.27B | Rp 53.10B | |
| Rp 47.09B | Rp 36.66B | Rp 40.66B | Rp 26.88B | Rp 49.91B | |
| Depreciation and Amortization | Rp 14.16B | Rp 13.63B | Rp 9.56B | Rp 8.79B | Rp 7.82B |
| Rp 32.93B | Rp 21.96B | Rp 17.94B | Rp 14.87B | Rp 10.61B | |
| Rp 20.37B | Rp 8.95B | Rp 5.84B | Rp 3.40B | Rp 3.19B | |
| Rp -2.84B | Rp -3.66B | Rp 387.34M | Rp 1.13B | Rp -508.63M | |
| Rp 17.52B | Rp 5.29B | Rp 6.23B | Rp 4.53B | Rp 2.68B | |
| Rp 13.51B | Rp 2.95B | Rp 2.19B | Rp 2.83B | Rp 308.25M | |
| Per Share Metrics | |||||
| Basic EPS | Rp 2.29 | Rp 0.50 | Rp 0.55 | Rp 0.72 | Rp 0.08 |
| Diluted EPS | Rp 2.29 | Rp 0.75 | Rp 0.55 | Rp 0.72 | Rp 0.08 |
| Weighted Average Shares Outstanding | 5.91B | 3.95B | 3.95B | 3.95B | 3.95B |
| Weighted Average Shares Outstanding (Diluted) | 5.91B | 3.95B | 3.95B | 3.95B | 3.95B |
Currency in IDR
